FDNA and Centogene Announce First Grant of Molecular Testing Under the Face2Gene Unknown Forum Grant Program at the American Society of Human Genetics (ASHG) Annual Meeting

Coffin-Lowry syndrome

October 17, 2016

BUSINESS WIRE – “Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics, enabled the first grant of molecular testing for a patient with an unknown genetic disorder. The collaboration extends beyond financial support and includes the successful integration of Face2Gene LABS API with CENTOGENE’s bioinformatics pipeline to improve variant prioritization and analysis of patients with undiagnosed genetic disorders using deep phenotyping and facial analysis technology.”

Related articles

Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading
Pioneering Rare Disease Diagnosis in Italy with AI-Powered Innovations, in Dermatology and Genetics

Pioneering Rare Disease Diagnosis in Italy with AI-Powered Innovations, in Dermatology and Genetics

In a recent landmark scientific webinar trailblazing development in dermatological phenotyping, genetic disorders, and the transformative application of artificial intelligence (AI) in rare disease diagnostics in Italy were explored. The event convened leading experts, researchers, and clinicians, who unveiled their experience in the clinic, including the innovative use of an AI-powered called Face2Gene to significantly […]

Continue reading